Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04016779

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Attention-Deficit/Hyperactivity Disorder (ADHD) Clinical Trial

Official title:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical Trial Summary

This study will evaluate the efficacy and safety of SPN-812 (Viloxazine extended-release capsules; 200-600 mg) in adults 18-65 years of age with Attention-Deficit/Hyperactivity Disorder (ADHD).

Clinical Trial Description

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, 2-arm, parallel-group, flexible dose trial assessing the efficacy and safety of SPN-812 (Viloxazine extended-release capsules; 200-600 mg) as monotherapy for the treatment of adults 18-65 years old with Attention-Deficit/Hyperactivity Disorder (ADHD). ;

Study Design

Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention-Deficit/Hyperactivity Disorder (ADHD)
  • Hyperkinesis
Clinical Trial Details
NCT number NCT04016779
Study type Interventional
Source Supernus Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 3
Start date November 20, 2019
Completion date October 10, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02150668 - Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD N/A
Completed NCT00631280 - Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD N/A
Recruiting NCT05809388 - Virtual Reality for Parent Training Intervention N/A
Completed NCT00776009 - Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. Phase 4
Recruiting NCT00252278 - Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents Phase 4
Completed NCT00307268 - Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD N/A
Completed NCT01107496 - Evaluation of Immediate-Release Viloxazine in Adults With ADHD Phase 1/Phase 2
Completed NCT04786990 - Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD Phase 4
Completed NCT00475735 - A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) Phase 2
Completed NCT00711724 - Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD N/A
Recruiting NCT06215144 - Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD Phase 2/Phase 3
Completed NCT02633527 - Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD Phase 2
Withdrawn NCT00323700 - A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD) N/A
Not yet recruiting NCT04532190 - Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder N/A
Withdrawn NCT00931398 - Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate Phase 4